Tenaya Therapeutics, Inc.
TNYA
$0.4912
$0.03066.64%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -6.24% | -22.18% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.71% | -13.34% | |||
| Operating Income | 7.71% | 13.34% | |||
| Income Before Tax | 7.01% | 12.90% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 7.01% | 12.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 7.01% | 12.90% | |||
| EBIT | 7.71% | 13.34% | |||
| EBITDA | 8.32% | 14.25% | |||
| EPS Basic | 7.26% | 13.37% | |||
| Normalized Basic EPS | 7.26% | 13.37% | |||
| EPS Diluted | 8.03% | 12.64% | |||
| Normalized Diluted EPS | 7.26% | 13.37% | |||
| Average Basic Shares Outstanding | 0.28% | 0.53% | |||
| Average Diluted Shares Outstanding | 0.28% | 0.53% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||